The country’s pharma plants have continued to run through the nationwide lockdown, and now a few cases of employees testing positive for the novel coronavirus (Covid-19) have started flowing in. While most hubs continue to operate despite these challenges, state regulators are on their toes to ensure that production is not hit and protocols are followed.
In Himachal’s Baddi, for example, some first information reports (FIRs), too, have been registered in cases where deviation to the advised protocol has been observed. With around 50 plants in Baddi, Himachal came under a containment zone area and the state FDA is now